Electra Private Equity plc (ELTA):企業の財務・戦略的SWOT分析

◆英語タイトル:Electra Private Equity plc (ELTA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010649
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:金融サービス
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥17,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Electra Private Equity plc (ELTA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Electra Private Equity Plc (Electra) offers portfolio analysis. Its offering includes investment portfolio analysis, buyouts and co-investments, debt investments, secondary investments, and core and non-core investment portfolio. Electra invests in sectors such as travel and leisure, media, house, leisure, and personal goods, private equity funds, support services, real estate, and private equity funds among others. Its investment focus is principally in the Western Europe region, particularly, in the UK. The company’s business operations are primarily managed by Epiris Managers LLP. Electra is headquartered in London, England, the UK.

Electra Private Equity plc Key Recent Developments

Dec 07,2017: Bramson steps down as CEO of Electra Private Equity
Sep 15,2017: Electra: Director declaration
Dec 12,2016: Electra Private Equity: Preliminary announcement for the Full Year ended 30 September 2016
Sep 07,2016: Retirement Bridge Group appoints former Partnership Group plc CEO Steve Groves as Chairman
Jul 22,2016: Electra appoints first CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Electra Private Equity plc – Key Facts 5
Electra Private Equity plc – Key Employees 6
Electra Private Equity plc – Key Employee Biographies 7
Electra Private Equity plc – Major Products and Services 8
Electra Private Equity plc – History 9
Electra Private Equity plc – Company Statement 11
Electra Private Equity plc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Electra Private Equity plc – Business Description 14
Electra Private Equity plc – SWOT Analysis 15
SWOT Analysis – Overview 15
Electra Private Equity plc – Strengths 15
Electra Private Equity plc – Weaknesses 16
Electra Private Equity plc – Opportunities 17
Electra Private Equity plc – Threats 18
Electra Private Equity plc – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Electra Private Equity plc, Recent Deals Summary 27
Section 4 – Company’s Recent Developments 28
Sep 15, 2017: Electra: Director declaration 28
Dec 12, 2016: Electra Private Equity: Preliminary announcement for the Full Year ended 30 September 2016 29
Sep 07, 2016: Retirement Bridge Group appoints former Partnership Group plc CEO Steve Groves as Chairman 30
May 04, 2016: Electra Private Equity: Announcement of unaudited results for the half year ended 31 March 2016 31
Apr 25, 2016: Electra Partners team developments 32
Apr 19, 2016: Electra Private Equity: Board appointment 33
Jan 28, 2016: Electra : Quarterly update report as at 31 December 2015 34
Section 5 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Electra Private Equity plc, Key Facts 5
Electra Private Equity plc, Key Employees 6
Electra Private Equity plc, Key Employee Biographies 7
Electra Private Equity plc, Major Products and Services 8
Electra Private Equity plc, History 9
Electra Private Equity plc, Other Locations 13
Electra Private Equity plc, Subsidiaries 13
Electra Private Equity plc, Key Competitors 19
Electra Private Equity plc, Ratios based on current share price 20
Electra Private Equity plc, Annual Ratios 21
Electra Private Equity plc, Annual Ratios (Cont...1) 22
Electra Private Equity plc, Annual Ratios (Cont...2) 23
Electra Private Equity plc, Interim Ratios 25
Electra Private Equity plc, Recent Deals Summary 27
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

★海外企業調査レポート[Electra Private Equity plc (ELTA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析
    Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting age …
  • Arcadia Group Limited:企業の戦略・SWOT・財務情報
    Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Basler Kantonalbank AG:企業の戦略・SWOT・財務情報
    Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Standard Chartered Bank Botswana Ltd (STANCHART):企業の財務・戦略的SWOT分析
    Standard Chartered Bank Botswana Ltd (STANCHART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • The Broad Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Norwegian Cruise Line Holdings Ltd. (NCLH):企業の財務・戦略的SWOT分析
    Norwegian Cruise Line Holdings Ltd. (NCLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Tulip Oil Holding BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Tulip Oil Holding BV (Tulip Oil) is an upstream oil and gas development and production company that explores and develops undeveloped oil and gas field discoveries. The company's activities include redeveloping abandoned or mature onshore oil and gas ?elds, developing onshore stranded oil an …
  • Celsion Corp (CLSN):医療機器:M&Aディール及び事業提携情報
    Summary Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), T …
  • Axon Enterprise, Inc.:戦略・SWOT・企業財務分析
    Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report Summary Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Al Rajhi Banking & Investment Corporation (1120):企業の財務・戦略的SWOT分析
    Al Rajhi Banking & Investment Corporation (1120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …
  • Luz Del Sur S.A.A (LUSURC1):企業の財務・戦略的SWOT分析
    Luz Del Sur S.A.A (LUSURC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Nestle Health Science SA:医療機器:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆